Date :
Place : United States of America, Boston
Website :https://oligonucleotides-cns.com/
Contact Person:Michelle Phan
Description:
Harnessing Antisense and RNA Chemistry, with Optimized Delivery and Reduced Toxicity, to Target Undruggable CNS Diseases. Time: 8:30 AM - 4:05 PM. Prices: USD 2599.00 - USD 5097.00.Deadline for abstracts/proposals : 27th August 2025
Organized By :
Keynote Speakers :
Conference Highlights :Home | 5th Oligonucleotides for CNS Summit
Unite with industry-leading 20+ speakers this August, to unleash the potential of ASOs, siRNAs and RNAi in neuroscience
Register By Friday, June 13To Save Up To $700
Uniting CNS Biotech & Pharma to Fuel the Next Wave of Oligonucleotide Drug Discovery, Translation & Clinical Progress
With clinical momentum fromEli Lilly’s lipidated brain shuttle siRNAs,Alnylam Pharmaceuticals’ ALN-APP siRNA,Wave’s Phase 1b/2a positive SELECT-HD data,170+ biotech and 30+ pharmaactive in the field, and a surge of novel approaches, the oligonucleotide field shows no signs of slowing down.
The5th Oligonucleotides for CNS Summitunites aselect group of industry-leadingbiologists, chemists, C-level executives, platform tech experts, DMPK and clinical pharmacologists, all tackling the unique challenges of CNS delivered ASOs, siRNAs, miRNAs and saRNAs.
This August, hear fromAlnylam Pharmaceuticals,Denali Therapeutics,Genentech,FDA,Novo Nordisk,Regeneron,Servier,Stoke Therapeutics,Ultragenyx Pharmaceuticaland more, to redefine the landscape of oligonucleotide research.
Check the event website for more details.